Use of stearate in an inhalable formulation
US10729647B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 10, 2018 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Jul 10, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.